A kind of pharmaceutical composition for treating essential hypertension
A technology of essential hypertension and composition, applied in the field of medicine, which can solve the problems of literature reports that did not find the antihypertensive activity of baogonglin
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0016] The following are specific examples of the present invention, and further describe the technical solution of the present invention, but the protection scope of the present invention is not limited to these examples. All changes or equivalent substitutions that do not depart from the concept of the present invention are included in the protection scope of the present invention.
[0017] Essential hypertensive rats (SHR), clean grade, 180-220g. The rats were randomly divided into the following three groups: the model control group, the positive control group and the patolicin group, with 10 rats in each group, half male and half male. After grouping, they were fed and observed for 3 days for the experiment. Each group was given the corresponding test substance according to the following doses:
[0018] Model control group: equal volume of purified water;
[0019] Positive control group: captopril 10mg / (kg·d);
[0020] Baogonggenalin group: Baogongalin 12mg / (kg·d).
...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com